DCN Corp
DCN Corp is a research and development company specializing in nanoparticle displacement technology to advance nano-scale solutions across multiple industries, particularly healthcare. Their proprietary 9 Combination (9c) Protocol enables precise control of nanoparticle coatings at nano-scale resolution, facilitating reproducible and eco-efficient nano-coatings. This technology underpins their flagship in-vitro diagnostic bio-kit designed for instant, at-home, and remote disease diagnosis, including cancer and cardiovascular conditions, aiming to revolutionize early screening and diagnostics. The company is focused on scaling production, achieving ISO compliance, and collaborating with industrial partners to commercialize their innovations, targeting the emerging Diagnostics 3.0 market integrating telemedicine and AI.
DCN Corp
DCN Corp is a research and development company specializing in nanoparticle displacement technology to advance nano-scale solutions across multiple industries, particularly healthcare. Their proprietary 9 Combination (9c) Protocol enables precise control of nanoparticle coatings at nano-scale resolution, facilitating reproducible and eco-efficient nano-coatings. This technology underpins their flagship in-vitro diagnostic bio-kit designed for instant, at-home, and remote disease diagnosis, including cancer and cardiovascular conditions, aiming to revolutionize early screening and diagnostics. The company is focused on scaling production, achieving ISO compliance, and collaborating with industrial partners to commercialize their innovations, targeting the emerging Diagnostics 3.0 market integrating telemedicine and AI.